Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,980.00
-20.00 (-0.33%)
At close: Feb 13, 2026
Market Cap68.03B -11.0%
Revenue (ttm)80.97B -11.7%
Net Income11.31B -24.9%
EPS978.54 -24.9%
Shares Out11.38M
PE Ratio6.11
Forward PEn/a
Dividend190.00 (3.18%)
Ex-Dividend Daten/a
Volume43,117
Average Volume48,520
Open6,000.00
Previous Close6,000.00
Day's Range5,910.00 - 6,020.00
52-Week Range5,640.00 - 7,200.00
Beta0.63
RSI53.40
Earnings DateMar 4, 2026

About Sinil Pharmaceutical

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In ... [Read more]

Industry Pharmaceutical Preparations
Founded 1971
Employees 287
Stock Exchange KOSDAQ
Ticker Symbol 012790
Full Company Profile

Financial Performance

In 2024, Sinil Pharmaceutical's revenue was 89.44 billion, an increase of 0.34% compared to the previous year's 89.14 billion. Earnings were 14.30 billion, an increase of 4.83%.

Financial Statements